Cogent Biosciences shareholders approve doubling authorized common stock to 300M shares

Cogent Biosciences, Inc.

Amendment increases authorized common shares from 150M to 300M; total authorized shares from 160M to 310M.
Outdated reverse stock split provisions deleted from the certificate of incorporation.
All three director nominees elected; Andrew Robbins received 67.8M for, Peter Harwin received 51.7M for.
Advisory vote on executive compensation passed with 69.6M for vs 6.7M against; future votes set for annual frequency.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.